Appointed: January 3, 2017
Committee membership: Remuneration Committee and Science & Technology Committee
Skills & experience: Ian brings to the Board his extensive leadership and biotechnology sector experience. Ian served as Chief Executive Officer and Director of Genentech Inc. (part of the Roche Group) and Head of North American Commercial Operations for Roche until 2016. From 2003 to 2010 he held the positions of Head of Global Product Strategy and Chief Marketing Officer, Executive Vice President – Commercial Operations and Senior Vice President and General Manager – BioOncology at Genentech. Prior to this Ian was appointed President of Novartis Canada, having previously served as Chief Operating Officer for Novartis United Kingdom. He also held various sales and marketing roles at Sanofi and Ivax. Ian holds a Bachelor's degree in Biological Sciences from the University of Southampton.
Key appointments: TerraVia Holdings Inc. (Non-Executive Director), Agios Pharmaceuticals, Inc. (Non-Executive Director), Corvus Pharmaceuticals, Inc. (Non-Executive Director), Kite Pharma, Inc. (Non-Executive Director) and Gladstone Institute (Member).